Objective We observed an unusually increased scrotal uptake as an interesting finding in some patients with prostate cancer who were scanned for any possible metastatic disease. This study was designed to investigate the significance of this incidental finding in the technetium-99m methylene diphosphonate scintigraphies. Methods The study population consisted of 104 patients with biopsy-proven prostate cancer (group I), 55 male patients with other cancers (group II), 30 male patients with nonmalignant diseases (group III) and finally 15 patients with benign prostate hypertrophy (group IV). The square-shaped regions of interest are placed centrally on the scrotum and then on the lateral femoral soft tissue. Then the simple ratios of the scrotal and femoral soft tissue mean counts (S/Bg) were calculated. The statistical significance of differences among the groups in terms of scrotal uptake was determined. Results Group I showed increased scrotal uptake relative to the other groups. The mean uptake ratios (S/Bg +/- standard deviation) were 3.49 +/- 1.42 in group I, 2.89 +/- 0.70 in group II, 2.87 +/- 0.75 in group III, and 2.91 +/- 0.60 in group IV. This ratio was significantly higher in patients with prostate cancer than the normal group (P=0.024), the group with benign prostate hypertrophy (P=0.004), and the patients with other cancers (P=0.004). Conclusion Our results showed that technetium-99m methylene diphosphonate bone scintigraphy, as a routine for detecting metastatic disease or performed for other purposes, could give clues for a hidden prostate cancer. Then, in elderly male patients, we strongly recommend that it is wise to keep one's eye on scrotal activity when bone scans are read and where there is any doubt, take appropriate regions of interest to make quantitative evaluations. Nucl Med Commun 32:155-158 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins. Nuclear Medicine Communications 2011, 32:155-158
机构:
Capital Med Univ, Beijing Friendship Hosp, Dept Nucl Med, Beijing 100050, Peoples R ChinaCapital Med Univ, Beijing Friendship Hosp, Dept Infect & Emergency, Beijing 100050, Peoples R China
Yang, Ji-Gang
Yin, Cheng-Hong
论文数: 0引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Friendship Hosp, Dept Infect & Emergency, Beijing 100050, Peoples R ChinaCapital Med Univ, Beijing Friendship Hosp, Dept Infect & Emergency, Beijing 100050, Peoples R China
Yin, Cheng-Hong
Li, Chun-Lin
论文数: 0引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Friendship Hosp, Dept Nucl Med, Beijing 100050, Peoples R ChinaCapital Med Univ, Beijing Friendship Hosp, Dept Infect & Emergency, Beijing 100050, Peoples R China
Li, Chun-Lin
Zou, Lan-Fang
论文数: 0引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Friendship Hosp, Dept Nucl Med, Beijing 100050, Peoples R ChinaCapital Med Univ, Beijing Friendship Hosp, Dept Infect & Emergency, Beijing 100050, Peoples R China
机构:
Capital Med Univ, Beijing Friendship Hosp, Dept Nucl Med, Beijing 100050, Peoples R ChinaCapital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing 100050, Peoples R China
Yang, Ji-Gang
Ma, Da-Qing
论文数: 0引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing 100050, Peoples R ChinaCapital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing 100050, Peoples R China
Ma, Da-Qing
Li, Chun-Lin
论文数: 0引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Friendship Hosp, Dept Nucl Med, Beijing 100050, Peoples R ChinaCapital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing 100050, Peoples R China
Li, Chun-Lin
Zou, Lan-Fang
论文数: 0引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Friendship Hosp, Dept Nucl Med, Beijing 100050, Peoples R ChinaCapital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing 100050, Peoples R China